Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2014
Renal impairment and late toxicity in germ-cell cancer survivorsJ Lauritsen, M S Mortensen, M G G Kier, et al.
Endocrine-Related Cancer|June 11, 2005
Tissue inhibitor of metalloproteinases-1 in breast cancerS Ø Würtz, A-S Schrohl, N Møller Sørensen, et al.
Journal of the National Cancer Institute|May 26, 1999
Plasma urokinase receptor levels in patients with colorectal cancer: relationship to prognosisR W Stephens, H J Nielsen, I J Christensen, et al.
Cancer Research|January 13, 2001
The complex between urokinase and its type-1 inhibitor in primary breast cancer: relation to survivalA N Pedersen, I J Christensen, R W Stephens, et al.
Transfusion Medicine (Oxford, England)|June 30, 2017
Randomised feasibility study of a more liberal haemoglobin trigger for red blood cell transfusion compared to standard practice in anaemic cancer patients treated with chemotherapyD Yakymenko, K B Frandsen, I J Christensen, et al.
Cancer Research|February 24, 2001
Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft modelT L Frandsen, C Holst-Hansen, B S Nielsen, et al.
Archives of Disease in Childhood|September 1, 1986
Prognostic value of different staging systems in neuroblastomas and completeness of tumour excisionN L Carlsen, I J Christensen, H Schroeder, et al.
Anticancer Research|May 1, 1987
Signs, symptoms, metastatic spread and metabolic behavior of neuroblastomas treated in Denmark during the period 1943-1980N L Carlsen, H Schroeder, I J Christensen, et al.
Gynecologic Oncology|August 25, 2001
Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseasesR Riisbro, R W Stephens, N Brünner, et al.
Scandinavian Journal of Immunology|January 5, 2011
Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancerH Ytting, I J Christensen, R Steffensen, et al.
Pageof 17